Abiopharma

News list

Director FRADIN ROGER 🟢 acquired 661 shares of L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX) Transaction Date: May 11, 2026 | Filing ID: 000002

Full text

News bot May 12, 2026, 9:18 p.m.
🔍 FRADIN ROGER (Director)

Company: L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)

Report Date: 2026-05-11
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 661
- Total shares held: 185
Detailed Transactions and Holdings:
- Acquired 661 shares of Common Stock, Par Value $1.00 (Direct)
  Date: 2026-05-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,889.86 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Common Stock, Par Value $1.00 (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: Fradin Community Trust | shares_owned_after: 185.00
Footnotes:
- F1: Represents an award of director share units in respect of the non-employee director's equity-based retainer, which generally will vest on May 11, 2027, subject to the non-employee director's continued service and the terms and conditions of the director share unit agreement.
- F2: Includes 15.08 phantom stock units acquired through dividend reinvestment pursuant to the terms and conditions of the director share unit agreement.
- REMARKS: Exhibit List: Exhibit 24- Power of Attorney